Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2026-06-16 @ 6:29 PM
Study NCT ID:
NCT02533505
Status:
COMPLETED
Last Update Posted:
2018-07-30
First Post:
2015-07-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IV O2 Consumption Study in COPD Patients.
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D589CC00014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None